Related Experiment Video

Updated: Aug 23, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Overview on the mechanisms of drug-induced liver cell death

Ignazio Grattagliano1, Piero Portincasa, Vincenzo O Palmieri

  • 1Department of Internal Medicine and Public Medicine (DIMIMP), University Medical School, Bari, Italy. igratta@tin.it

Annals of Hepatology
|July 29, 2004
PubMed

Insights

Drug-induced hepatotoxicity is unpredictable due to gaps in understanding liver cell death mechanisms. This review covers intra/extracellular factors, mitochondria, and non-parenchymal cells to improve management of drug-induced liver injury.

Area of Science:

  • Hepatology
  • Toxicology
  • Cell Biology

Background:

  • Drug-induced hepatotoxicity presents a significant clinical challenge.
  • Current preclinical assessments often fail due to incomplete knowledge of toxicity mechanisms.
  • This leads to unpredictable drug-induced liver injury (DILI).

Purpose of the Study:

  • To review current knowledge on mechanisms of drug-induced liver cell death.
  • To discuss the roles of intra- and extracellular factors in DILI.
  • To examine the involvement of mitochondria and non-parenchymal cells in DILI.

Main Methods:

  • Literature review of existing research on drug-induced hepatotoxicity.
  • Analysis of cellular and molecular mechanisms underlying liver cell death.
  • Synthesis of information on factors influencing apoptosis and necrosis in DILI.

Main Results:

  • Drug-induced liver cell death involves complex intra- and extracellular signaling pathways.
  • Mitochondrial dysfunction plays a critical role in the pathogenesis of DILI.
  • Non-parenchymal liver cells contribute significantly to the inflammatory response and injury progression.

Conclusions:

  • A comprehensive understanding of DILI mechanisms is crucial for improving preclinical drug safety evaluations.
  • Targeting mitochondrial pathways and modulating non-parenchymal cell activity may offer therapeutic strategies for DILI.
  • Further research into these mechanisms is essential for developing safer therapeutics and managing DILI effectively.

More Related Videos

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...